Don Kalkofen | Chief Financial Officer |
Dinesh Patel | President and Chief Executive Officer |
Samuel Saks | Chief Medical Officer |
Ronald Hoffman | M.D., Director of the Myeloproliferative Diseases Program |
Chris Marai | Nomura |
Gobind Singh | BMO |
Joe Schwartz | Leerink |
Chris Bialas | HCW |
Good day, and welcome to the Protagonist Therapeutics PTG-300 Development Update Call. Please note that today's conference is being recorded.
At this time, I would like to introduce Don Kalkofen, Protagonist's Chief Financial Officer. Please go ahead.
Thank you, operator.